起订量:
130-119-483 Ovarian TumorMACS™ Medium
高级会员第8年
代理商北京百奥创新科技有限公司是中关村高新技术企业,于2017年在北京成立。依托中科院的科研技术力量,整合经验丰富的商业团队及管理团队组建而成,专注于免疫学、细胞生物学、分子生物学等领域核心试剂产品的研发、生产与销售。百奥创新在产品自主研发的同时,也与全球多家生命科学试剂供应商建立良好的合作关系,基于“客户第一”的核心理念,向全国10000+客户提供200000+优质产品。公司以北京运营中心为主体,在天津、上海、浙江、江苏、广州、深圳、武汉、成都、重庆等地建立办事处及联络中心,并建有北京、天津、深圳三大专业化库存与物流基地,以更好地服务全国客户。
百奥创新将以品质树立品牌,以服务赢得口碑,致力于成长为重要的生物原料及生物化学试剂开发与成果转化的leader,并成为行业ling-xian的优质供应商。
Overview:Ovarian TumorMACS™ Medium is an optimized serum-free cell culture medium for the c*tion and expansion of tumor cells from primary and xenotransplanted ovarian tumors. It enables the establishment of stable cell lines from freshly dissociated tumor tissue.
Detailed product information:The Ovarian TumorMACS™ Medium is an optimized and standardized medium for the reliable expansion of specific tumor cells from primary or xenotransplanted human ovarian tumor samples. Tumor cells from freshly dissociated tissue can be cultured over multiple passages, allowing for in vitro assays, such as drug screenings on primary cell cultures or characterization studies including gene expression or protein profiling. In addition, the Ovarian TumorMACS Medium supports the establishment of new cell lines and thereby obtaining sufficient cell numbers for further experiments, such as in vivo transplantation studies in animals. Ovarian TumorMACS Medium efficiently expands cultures of specific primary ovarian tumor cells in vitro while maintaining the cell populations’ heterogeneity and tumorigenic potential. The medium is manufactured under strictly controlled conditions using ingredients of the highest quality. Ovarian TumorMACS Medium offers consistent lot-to-lot performance and optimal conditions for the c*tion of specific primary ovarian tumor cells.